Skip to main content

Spectrum: Autism Research News

Tag: clinical trials

October 2018
Illustration of research mice forming the letter 'X'.

Fragile X syndrome’s link to autism, explained

by  /  10 October 2018

Fragile X syndrome is a leading genetic cause of autism. People who have either condition often share certain traits, such as difficulties in social situations.

Photograph of marijuana plant in dark setting.

Drug agency ruling on marijuana may do little to ease autism research

by  /  1 October 2018

The U.S. Drug Enforcement Agency has made it legal for doctors to prescribe an epilepsy drug derived from marijuana. But all other compounds derived from marijuana remain under tight restrictions.

September 2018

Ecstasy ingredient touted as treatment for anxiety in autism

by  /  25 September 2018

The active ingredient in the drug popularly known as ecstasy eases social anxiety in people with autism.

Gate keepers with long documents and spears in front of fortress full of marijuana leaves.

Federal chokehold on marijuana stymies studies on epilepsy, autism

by  /  11 September 2018

Scientists’ desire for evidence-based medical inquiry runs headlong into an apparently immovable obstacle: the U.S. Drug Enforcement Agency.

August 2018
silver scissors float on white, about to cut a red ribbon.

Outcry compels NIH to put new clinical trial policy on hold

by  /  23 August 2018

Responding to serious concerns about its policy defining certain kinds of research as ‘clinical trials,’ the U.S. National Institutes of Health has postponed enforcing parts of the policy until September 2019.

Collage illustration shows sun rising behind medicine dropper with marijuana leaves growing out of it.

Drug approval could boost research on marijuana treatment for autism

by  /  16 August 2018

The United States has approved a compound derived from marijuana as a treatment for certain types of epilepsy. The ruling may spell good news for autism research.

July 2018

Skepticism surrounds autism drug given ‘fast track’ for approval

by  /  25 July 2018

In May, the U.S. Food and Drug Administration guaranteed an experimental autism drug a speedy review for approval, but some scientists are skeptical of the drug’s potential.

A whimsical illustration shows scientists as flowers, being 'watered' by Euros, which is also filtering down into a system of lab objects and medicines.

Record-breaking grant may fuel autism drug development

by  /  19 July 2018

A huge new research collaboration may jump-start the race to develop therapies for autism.


Webinar: Orrin Devinsky discusses cannabis compounds for epilepsy

 /  17 July 2018

Watch the complete replay of Orrin Devinsky discussing cannabis-based treatments for seizures.

June 2018
Illustration of person looking at a car, with a window into their brain activity.

Despite dearth of data, firms sell brain training as autism antidote

by  /  28 June 2018

Many clinics offer neurofeedback as a therapy for autism, despite little scientific support for the technique.

1 Comment